3-Part Investigative Series on Merck’s Gardasil® Highlights Government Conflicts of Interest in Vaccine Development, Approval and Safety Surveillance
By VT / May 20, 2010PRNewswire.com 05/19/2010 The Coalition for Vaccine Safety (CVS) calls for independent vaccine safety agency and Congressional hearings on government’s lax record on safety issues WASHINGTON, May 19 /PRNewswire-USNewswire/ — A three-part investigative series on Merck’s cervical cancer vaccine, Gardasil®, highlights serious conflicts of interest across agencies of the Department of Health and Human Services (DHHS) […]